BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 49 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,427 | -96.4% | 97,088 | -40.3% | 0.00% | -100.0% |
| Q1 2023 | $537,085 | +1828.9% | 162,753 | +858.6% | 0.00% | – |
| Q4 2022 | $27,844 | -58.4% | 16,978 | -29.7% | 0.00% | – |
| Q2 2022 | $67,000 | -59.4% | 24,134 | -50.8% | 0.00% | – |
| Q1 2022 | $165,000 | -35.3% | 49,097 | -26.2% | 0.00% | – |
| Q1 2021 | $255,000 | -45.6% | 66,512 | -35.9% | 0.00% | -100.0% |
| Q4 2020 | $469,000 | +143.0% | 103,738 | +130.2% | 0.00% | 0.0% |
| Q4 2019 | $193,000 | -60.9% | 45,059 | -64.4% | 0.00% | -75.0% |
| Q3 2019 | $493,000 | +12.3% | 126,459 | +13.7% | 0.00% | 0.0% |
| Q2 2019 | $439,000 | +116.3% | 111,245 | +137.6% | 0.00% | +100.0% |
| Q1 2019 | $203,000 | +463.9% | 46,823 | +365.1% | 0.00% | – |
| Q4 2018 | $36,000 | +1100.0% | 10,067 | +1577.8% | 0.00% | – |
| Q2 2017 | $3,000 | -66.7% | 600 | -72.5% | 0.00% | – |
| Q1 2017 | $9,000 | -18.2% | 2,180 | -43.9% | 0.00% | – |
| Q4 2015 | $11,000 | +22.2% | 3,883 | 0.0% | 0.00% | – |
| Q3 2015 | $9,000 | -43.8% | 3,883 | -11.4% | 0.00% | – |
| Q2 2015 | $16,000 | – | 4,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABNER HERRMAN & BROCK LLC | 241,500 | $1,093,000 | 0.17% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 90,584 | $410,000 | 0.13% |
| EPIQ PARTNERS, LLC | 10,550 | $48,000 | 0.03% |
| Phoenix Holdings Ltd. | 173,683 | $799,000 | 0.02% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 5,500 | $25,000 | 0.02% |
| CFO4Life Group, LLC | 12,003 | $54,000 | 0.02% |
| HighPoint Advisor Group LLC | 15,733 | $115,000 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 357,761 | $1,619,000 | 0.01% |
| Virtu Financial LLC | 24,484 | $111,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 93,902 | $435,000 | 0.01% |